PFE
21
-2
LB
82
19
CINF
48
3
GOOG
71
-6
XRAY
29
3
BEN
34
-3
STI
17
10
WDC
50
-2
IRM
46
5
MCO
77
7
RF
66
3
NWS
83
4
LH
50
2
PHM
63
4
WMT
63
3
LYB
41
-2
ED
46
3
CF
48
-5
STZ
50
2
EW
27
2
PFE
21
-2
LB
82
19
CINF
48
3
GOOG
71
-6
XRAY
29
3
BEN
34
-3
STI
17
10
WDC
50
-2
IRM
46
5
MCO
77
7
RF
66
3
NWS
83
4
LH
50
2
PHM
63
4
WMT
63
3
LYB
41
-2
ED
46
3
CF
48
-5
STZ
50
2
EW
27
2
Financhill
Back

United Therapeutics Quote, Financials, Valuation and Earnings

U.S. Government Report Alert Tuesday

Discover the Secret Loophole
Buy
67

UTHR
United Therapeutics

Last Price:
410.82
Seasonality Move:
4.71%

7 Day Trial

ALL ACCESS PASS

$ 7

The Mysterious VC Firm Behind Nvidia's Secret Weapon

Details Here!

United Therapeutics Price Quote

$410.82
+0.82 (+2.05%)
(Updated: November 9, 2024 at 5:51 AM ET)

United Therapeutics Key Stats

Buy
67
United Therapeutics (UTHR) is a Buy
Day range:
$403.35 - $417.82
52-week range:
$208.62 - $417.82
Dividend yield:
0%
P/E ratio:
20.70
P/S ratio:
7.27
P/B ratio:
3%
Volume:
497.1K
Avg. volume:
324.3K
1-year change:
81.63%
Market cap:
$18.3B
Revenue:
$2.3B
EPS:
$22.77

How Much Does United Therapeutics Make?

Is United Therapeutics Growing As A Company?

  • What Is United Therapeutics's Growth Rate Quarterly?
    Quarterly YoY revenue growth is 0.23%
  • What Is United Therapeutics's EPS Quarterly YoY Growth Rate?
    Quarterly, year-over-year diluted EPS growth rate is 0.19%

United Therapeutics Stock Price Performance

What Is United Therapeutics 52-Week High & Low?

United Therapeutics Price To Free Cash Flow

Is It Risky To Buy United Therapeutics?

Is United Therapeutics Cash Flow Positive?

  • What Is UTHR Cash Flow From Operations?
    Cash flow from operations (TTM) is $1.1B
  • What Is United Therapeutics’s Cash Flow From Financing?
    Cash flow from financing (TTM) is -$1.3B
  • What Is United Therapeutics’s Cash Flow From Investing?
    Cash flow from investing (TTM) is $582.5M

United Therapeutics Return On Invested Capital

  • Is Management Doing A Good Job?
    UTHR return on invested capital is 17.45%
  • What Is United Therapeutics Return On Assets?
    ROA measures how assets are converting to revenues and is 16.09%
  • What Is UTHR Return On Equity?
    ROE is a measure of profitability and is 19.26%

United Therapeutics Earnings Date & Stock Price

United Therapeutics Competitors

United Therapeutics Dividend Yield

United Therapeutics Analyst Estimates

YoY Growth Past Surprise
EPS: 18.77% -2.19%
Revenue: 22.89% 3.61%

Analyst Recommendations

Buy Recommendations: 7
Hold Recommendations: 5
Sell Recommendations: 1
Price Target: 382.29
Downside from Last Price: -6.76%

Major Shareholders

  • How many UTHR shares are owned by institutional investors?
    81.4M UTHR shares are owned by institutional investors
  • How many UTHR shares are owned by insiders?
    125.5K UTHR shares are owned by insiders